SciBase Holding AB (publ) (STO:SCIB)

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Skincancer	38.38M	28.04M	21.83M	16.31M	10.69M
Skincancer Growth	36.91%	28.45%	33.84%	52.50%	15.96%
The Skin Barrier Function	2.08M	1.67M	1.42M	1.58M	1.03M
The Skin Barrier Function Growth	24.51%	17.62%	-10.36%	53.09%	244.67%
Total	40.46M	29.70M	23.25M	17.89M	11.73M
Total Growth	36.21%	27.79%	29.93%	52.55%	23.17%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Germany	25.00M	22.59M	20.25M	13.83M	8.72M
Germany Growth	10.67%	11.52%	46.39%	58.68%	0.69%
Sweden	2.02M	1.76M	982.00K	1.35M	950.00K
Sweden Growth	15.21%	78.82%	-27.10%	41.79%	-
USA	13.44M	5.36M	2.01M	2.71M	2.06M
USA Growth	150.62%	166.73%	-25.77%	31.57%	-
Total	40.46M	29.71M	23.25M	17.89M	11.73M
Total Growth	36.21%	27.79%	29.93%	52.55%	23.18%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 13, 2026

Data Sources Report a data error